Axa S.A. Catalent, Inc. Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$45.44 - $74.26 $3.27 Million - $5.34 Million
-71,862 Reduced 41.14%
102,835 $6.76 Million
Q4 2022

Feb 14, 2023
BUY
$41.39 - $81.0 $65,189 - $127,575
1,575 Added 0.91%
174,697 $7.86 Million
Q3 2022

Feb 14, 2023
SELL
$72.36 - $113.1 $520,123 - $812,962
-7,188 Reduced 3.99%
173,122 $12.5 Million
Q3 2022

Nov 14, 2022
SELL
$72.36 - $113.1 $520,123 - $812,962
-7,188 Reduced 3.99%
173,122 $12.5 Million
Q2 2022

Feb 14, 2023
SELL
$87.2 - $114.05 $162,628 - $212,703
-1,865 Reduced 1.02%
180,310 $19.3 Million
Q2 2022

Aug 15, 2022
SELL
$87.2 - $114.05 $162,628 - $212,703
-1,865 Reduced 1.02%
180,310 $19.3 Million
Q1 2022

Feb 14, 2023
BUY
$94.19 - $124.49 $852,702 - $1.13 Million
9,053 Added 5.23%
182,175 $20.2 Million
Q1 2022

May 13, 2022
SELL
$94.19 - $124.49 $4.19 Million - $5.54 Million
-44,483 Reduced 19.63%
182,175 $20.2 Million
Q4 2021

Feb 14, 2022
SELL
$119.57 - $139.07 $1.34 Million - $1.56 Million
-11,190 Reduced 4.7%
226,658 $29 Million
Q3 2021

Nov 15, 2021
SELL
$109.17 - $142.35 $938,862 - $1.22 Million
-8,600 Reduced 3.49%
237,848 $31.7 Million
Q2 2021

Aug 13, 2021
SELL
$100.34 - $115.69 $1.03 Million - $1.18 Million
-10,229 Reduced 3.99%
246,448 $26.6 Million
Q1 2021

May 14, 2021
BUY
$101.51 - $125.27 $240,375 - $296,639
2,368 Added 0.93%
256,677 $27 Million
Q4 2020

Feb 12, 2021
BUY
$85.88 - $105.36 $922,265 - $1.13 Million
10,739 Added 4.41%
254,309 $26.5 Million
Q3 2020

Nov 13, 2020
SELL
$72.74 - $92.5 $2.35 Million - $2.99 Million
-32,327 Reduced 11.72%
243,570 $20.9 Million
Q2 2020

Aug 14, 2020
SELL
$48.02 - $79.04 $1.37 Million - $2.25 Million
-28,466 Reduced 9.35%
275,897 $20.2 Million
Q1 2020

May 15, 2020
BUY
$36.95 - $62.95 $2.64 Million - $4.49 Million
71,326 Added 30.61%
304,363 $15.8 Million
Q4 2019

Feb 18, 2020
BUY
$47.06 - $56.64 $1.78 Million - $2.14 Million
37,750 Added 19.33%
233,037 $13.1 Million
Q3 2019

Nov 14, 2019
SELL
$47.45 - $58.05 $2.37 Million - $2.89 Million
-49,852 Reduced 20.34%
195,287 $9.31 Million
Q2 2019

Aug 13, 2019
SELL
$39.26 - $54.21 $1.23 Million - $1.7 Million
-31,436 Reduced 11.37%
245,139 $13.3 Million
Q1 2019

May 14, 2019
BUY
$29.84 - $43.92 $824,867 - $1.21 Million
27,643 Added 11.1%
276,575 $11.2 Million
Q4 2018

Feb 13, 2019
BUY
$29.95 - $46.34 $1.45 Million - $2.24 Million
48,253 Added 24.04%
248,932 $7.76 Million
Q3 2018

Nov 08, 2018
BUY
$40.12 - $45.55 $238,192 - $270,430
5,937 Added 3.05%
200,679 $9.14 Million
Q1 2018

May 14, 2018
BUY
$39.4 - $47.39 $7.67 Million - $9.23 Million
194,742 New
194,742 $8 Million

Others Institutions Holding CTLT

# of Institutions
514
Shares Held
149M
Call Options Held
575K
Put Options Held
2.03M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email